Evidence map›Paper›PMID 26324809›Full record

ReviewEuropean respiratory review : an official journal of the European Respiratory Society2015

National and regional asthma programmes in Europe.

Olof Selroos, Maciej Kupczyk, Piotr Kuna, Piotr Łacwik, Jean Bousquet, David Brennan, Susanna Palkonen, Javier Contreras, Mark FitzGerald, Gunilla Hedlin and 9 more

Erratum issued Registry-linked trialAbstract readReview
In one paragraph

Review in European respiratory review : an official journal of the European Respiratory Society, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It is linked to trial NCT06652542 (Asthma Exacerbations & Respiratory Management), which is not on this map. Cited by 63 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
63citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06652542 completednot on this mapstarted 2024, after this paper: background citation

Asthma Exacerbations & Respiratory Management: An International Online Survey Endorsed by the International Association of Non-invasive Ventilation & International College of Experts

TypeobservationalSponsorAssiut UniversityRan2024 to 2025Enrolled93ConditionsAcute Asthma Exacerbations
3 · Its place in the literature

Who cites it

63 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Bacterial lysate therapy for the prevention of wheezing episodes and asthma exacerbations: a systematic review and meta-analysis.European respiratory review : an official journal of the European Respiratory Society · 2020
    Pooled it
  2. Trial
  3. Article
  4. Review
  5. Plant MicrofungiInternational journal of molecular sciences · 2026
    Article
  6. Review
  7. Development of the Respiratory System During Adolescence.Advances in experimental medicine and biology · 2026
    Review
  8. Article
  9. Review
  10. MicrofungusCells · 2025
    Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Information Needs of State-Level Asthma Programs: Recommendations to Increase Accessibility.International journal of environmental research and public health · 2024
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review

3 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

19 authors.

Olof SelroosSelroos Medical Consulting (Semeco AB), Ängelholm, Sweden olof.selroos@telia.com.
Maciej KupczykDept of Internal Medicine, Asthma and Allergy, Barlicki University Hospital, Medical University of Lodz, Lodz, Poland.
Piotr KunaDept of Internal Medicine, Asthma and Allergy, Barlicki University Hospital, Medical University of Lodz, Lodz, Poland.
Piotr ŁacwikDept of Internal Medicine, Asthma and Allergy, Barlicki University Hospital, Medical University of Lodz, Lodz, Poland.
Jean BousquetNational Institute for Health and Medical Research (INSERM), Paris, France.
David BrennanEuropean Federation of Asthma and Airways Diseases Patients' Association (EFA), Brussels, Belgium.
Susanna PalkonenEuropean Federation of Asthma and Airways Diseases Patients' Association (EFA), Brussels, Belgium.
Javier ContrerasNational Federation of Respiratory Disease Associations (FENAER), Malaga, Spain.
Mark FitzGeraldInstitute for Heart and Lung Health, Vancouver, Canada.
Gunilla HedlinCentre for Allergy Research, Karolinska Institutet, Stockholm, Sweden.
Sebastian L JohnstonAirway Disease Infection Section, National Heart and Lung Institute, Imperial College, London, UK.
Renaud LouisDept of Pneumology, CHU Sart-Tilman Liège, Liège, Belgium.
Leanne MetcalfAsthma UK, London, UK.
Samantha WalkerAsthma UK, London, UK.
Antonio Moreno-GaldóPediatric Pulmonology Unit, Hospital Vall d'Hebron, Barcelona, Spain.
Nikolaos G PapadopoulosDept of Allergology, University of Athens, Athens, Greece.
José Rosado-PintoImmunoallergology Dept, Hospital da Luz, Lisbon, Portugal.
Pippa PowellEuropean Lung Foundation, Sheffield, UK.
Tari HaahtelaSkin and Allergy Hospital, Helsinki University Central Hospital, Helsinki, Finland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This review presents seven national asthma programmes to support the European Asthma Research and Innovation Partnership in developing strategies to reduce asthma mortality and morbidity across Europe. From published data it appears that in order to influence asthma care, national/regional asthma programmes are more effective than conventional treatment guidelines. An asthma programme should start with the universal commitments of stakeholders at all levels and the programme has to be endorsed by political and governmental bodies. When the national problems have been identified, the goals of the programme have to be clearly defined with measures to evaluate progress. An action plan has to be developed, including defined re-allocation of patients and existing resources, if necessary, between primary care and specialised healthcare units or hospital centres. Patients should be involved in guided self-management education and structured follow-up in relation to disease severity. The three evaluated programmes show that, thanks to rigorous efforts, it is possible to improve patients' quality of life and reduce hospitalisation, asthma mortality, sick leave and disability pensions. The direct and indirect costs, both for the individual patient and for society, can be significantly reduced. The results can form the basis for development of further programme activities in Europe.

Indexed as

Health Services AccessibilityNational Health ProgramsRegional Health PlanningAsthmaEuropeHumansPractice Guidelines as TopicProgram DevelopmentQuality ImprovementQuality Indicators, Health CareTime FactorsTreatment Outcome

Identifiers

PMID26324809
PMCPMC9487682

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.